Through the editorial staff of Allodocteurs.fr, with AFP
Fewer and fewer elderly deaths. The share of people over 80 in deaths from covid-19 in Europe has fallen to its lowest level since the start of the pandemic, revealed on April 15 Hans Kluge, regional director of the World Health Organization. Health. This share fell gradually “at about 30%“of deaths, against 62% in mid-January, according to the WHO.
Read also: Covid: the milestone of 100,000 dead soon to be crossed according to Public Health France
“Over the past two months, the trend among those over 80 has deviated from the trend observed in all other age groups“said Hans Kluge.
This decline “could be due to the large share of vaccination in this high risk group” he added.
160 new cases per minute
And more generally, vaccination seems to be bearing fruit in Europe. When at the beginning of April, the WHO deplored a number of cases “most disturbing in months“with a rapid and continuous rise, she is now seeing”warning signs that transmission may be slowing in several countries“.
The organization nevertheless calls for maintaining vigilance, at a time when 160 new cases are reported every minute on average in Europe, according to its data. “The first signs of decline are not synonymous with low transmission rates. Transmission must be brought down to low rates and remain low“, underlined Mr. Kluge.
Continue to use AstraZeneca
In the European Union, the vaccination campaign allowed 16.9% of the population to receive a first dose of the vaccine, according to official data compiled by AFP on Thursday.
Currently, four vaccines are authorized in the European Union: Pfizer, Moderna, AstraZeneca and Johnson & Johnson. For the latter, the WHO reaffirmed that it would communicate “soon“his findings following his suspension in the United States after cases of thrombosis.
The organization also called for continued use of the AstraZeneca vaccine, which was completely abandoned on April 14 for the first time by a European country, Denmark. “Today, the risk of developing blood clots is much higher for someone with covid-19 than for someone who has received the AstraZeneca vaccine.“, pointed out Mr. Kluge.